Table 4 Lines of management and duration of hospital stay in studied patients
| Â | Group I (n = 32) | Group II (n = 28) | P value |
|---|---|---|---|
Anticoagulants | Â | Â | 0.23 |
 UFH then warfarin | 10 (31.3%) | 14 (50%) |  |
 UFH then NOAC | 0 | 1 (3.6%) | |
 LMWH and Warfarin | 19 (59.4%) | 10 (35.7%) | |
 NOAC | 3 (9.4%) | 3 (10.7%) | |
Thrombolytic therapy | 0 | 10 (35.7%) | < 0.001 |
Embolectomy | 0 | 1 (3.6%) | 0.46 |
Hospital stay ( in days) | 6.41 ± 1.84 | 13.96 ± 1.55 | 0.001 |